- Nachrichtendetail
-
18.06.2024 08:06:48 - dpa-AFX: *ASTRAZENECA SAYS CAPITELLO-290 PHASE III TRIAL FOR TRUQAP + CHEMOTHERAPY FAILS TO MEET DUAL PRIMARY ENDPOINTS OF IMPROVEMENT IN OVERALL SURVIVAL
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ASTRAZENECA PLC DL-,25 | 886455 | Frankfurt | 147,250 | 27.06.24 15:28:03 | -2,750 | -1,83% | 146,500 | 147,950 | 147,550 | 150,000 |
